Advertisement
The U.S. Food and Drug Administration has approved Onivyde (irinotecan liposome injection) to be used in combination with fluorouracil and leucovorin in advanced pancreatic cancer.

FDA Approves Onivyde for Metastatic Pancreatic Cancer

0
To be used in combination with fluorouracil/leucovorin for advanced disease
Chemoradiotherapy is associated with survival benefit over chemotherapy alone for elderly patients with limited-stage small-cell lung cancer

CRT May Be Preferred Strategy for Elderly With Lung Cancer

0
Increased survival for chemoradiotherapy versus chemotherapy in limited-stage, small-cell lung cancer
Many physicians are inconsistent or behind schedule in their recommendations for human papillomavirus vaccination

Many Doctors Inconsistent With HPV Vaccine Recommendations

0
Sizeable minority does not strongly endorse vaccination nor deliver timely recommendations
Nicotinamide appears to reduce non-melanoma skin cancers by 23 percent when taken twice daily

Nicotinamide Could Protect Against Some Skin Cancers

0
High-risk patients who took nicotinamide daily developed fewer non-melanoma lesions
In Australia

Cancers Differ in Indigenous, Non-Indigenous Populations

0
Generally, indigenous cancer rates lower, except for lung cancer in men, cervical in women
Hypofractionated radiation therapy with incorporated boost over a shorter period of time treats early-stage breast cancer as well as longer

ASTRO: Shorter Radiation OK for Early Breast Cancers

0
High-dose therapy shows same survival rates as longer course of standard radiation
Cardiac surgery patients given blood stored for more than six weeks face no greater harm than those who get blood donated within two weeks

Older Blood Appears Safe for Cardiac Surgery Patients

0
Storage duration doesn't affect complications, mortality rate
Coagadex (coagulation Factor X) has been approved by the U.S. Food and Drug Administration as the first coagulation factor replacement therapy for people with a rare blood disorder known as hereditary Factor X deficiency.

FDA Approves Coagadex for Rare Clotting Disorder

0
First coagulation therapy sanctioned for Factor X deficiency
For patients with metastatic squamous non-small-cell lung cancer

Report Details Benefits, Risks of Nivolumab for Squamous NSCLC

0
Benefit-risk summary shows beneficial effects for patients with metastatic SQ NSCLC
For patients with colorectal cancer

SNORA42 Identified as Novel Oncogene in Colorectal Cancer

0
Increased SNORA42 expression is independent prognostic factor for overall, disease-free survival